All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Pfizer Inc., of New York, said detailed results from the phase II PALOMA-1 study of palbociclib in combination with letrozole vs. letrozole alone were published in The Lancet Oncology.